Omphis Foundation

Omphis Foundation is a non-profit biotechnology organization focused on developing treatments for rare and neglected diseases, particularly neuronopathic Gaucher disease (Types 2 and 3). The foundation utilizes a venture philanthropy model to advance therapeutic candidates that may not attract traditional commercial investment due to small patient populations. By collaborating with academic researchers and industry partners, Omphis aims to bridge the gap between basic research and clinical application. Their current efforts include the development of small molecule chaperones and the optimization of existing compounds to cross the blood-brain barrier and restore enzyme function in the central nervous system. The organization is committed to ensuring that resulting therapies are accessible and affordable for patients globally. Omphis is led by experienced biotech entrepreneurs and scientists dedicated to addressing the unmet needs of the rare disease community.